Strategies for the Nuclear Delivery of Metal Complexes to Cancer Cells

Abstract

AbstractThe nucleus is an essential organelle for the function of cells. It holds most of the genetic material and plays a crucial role in the regulation of cell growth and proliferation. Since many antitumoral therapies target nucleic acids to induce cell death, tumor‐specific nuclear drug delivery could potentiate therapeutic effects and prevent potential off‐target side effects on healthy tissue. Due to their great structural variety, good biocompatibility, and unique physico‐chemical properties, organometallic complexes and other metal‐based compounds have sparked great interest as promising anticancer agents. In this review, strategies for specific nuclear delivery of metal complexes are summarized and discussed to highlight crucial parameters to consider for the design of new metal complexes as anticancer drug candidates. Moreover, the existing opportunities and challenges of tumor‐specific, nucleus‐targeting metal complexes are emphasized to outline some new perspectives and help in the design of new cancer treatments.